Baseline Analysis of MINDFuL Trial Highlights Screening Success of Enrolling Patients With Immune Dysfunction

Published Date: 09 Apr 2025

Data suggests that immune dysfunction biomarkers do not pose a major barrier to patient enrollment in Alzheimer’s research, as most patients meeting general AD criteria also qualified under immune dysfunction criteria.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Lesser-known lobular breast cancer on the rise in U.S. women

2.

Study finds that AI is better at forecasting the risk of developing cancer.

3.

Kate Middleton and Remission: Oncologists Weigh In

4.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

5.

What Role Should Genomic Classifier Testing Play in Prostate Cancer?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot